Benzinga | May 3, 2021 07:10AM EDT

Karyopharm Therapeutics Q1 EPS $(0.77) Misses $(0.71) Estimate, Sales $23.26M Miss $25.17M Estimate

Karyopharm Therapeutics (NASDAQ:KPTI) reported quarterly losses of $(0.77) per share which missed the analyst consensus estimate of $(0.71) by 8.45 percent. This is a 1.28 percent increase over losses of $(0.78) per share from the same period last year. The company reported quarterly sales of $23.26 million which missed the analyst consensus estimate of $25.17 million by 7.59 percent. This is a 28.24 percent increase over sales of $18.14 million the same period last year.